no statement of use filed
on 13 Jun 2022
Last Applicant/ Owned by
201 King of Prussia Road, Suite 501
Radnor
PA
19087
Serial Number
88758052 filed on 14th Jan 2020
Registration Number
N/A
Correspondent Address
Joshua M. Gerben, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Manufacturing services for others in the fields of biological products, biopharmaceutical products, regenerative medicine products, combination biologic/device products, or viral and non-viral vectors for use in gene therapy, modified gene therapy, cell therapy, tissue engineering; Manufacturing services for others in the fields of biopharmaceuticals; Manufacturing services for others in the field Read More
Rental of office machinery and equipment
Rental of office space
Manufacturing services for others in the fields of biological products, biopharmaceutical products, regenerative medicine products, combination biologic/device products, or viral and non-viral vectors for use in gene therapy, modified gene therapy, cell therapy, tissue engineering; Manufacturing services for others in the fields of biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
Rental of laboratory apparatus and instruments; Rental of laboratory equipment; Rental of laboratory instruments; Scientific laboratory services; Rental of laboratory facilities; Leasing of laboratories containing laboratory equipment for scientific research; Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research
No 88758052
No Service Mark
No 07768-0014
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Jun 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
13th Jun 2022 | ABANDONMENT - NO USE STATEMENT FILED |
16th Sep 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
14th Sep 2021 | SOU EXTENSION 2 GRANTED |
14th Sep 2021 | SOU EXTENSION 2 FILED |
14th Sep 2021 | TEAS EXTENSION RECEIVED |
13th Mar 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
11th Mar 2021 | SOU EXTENSION 1 GRANTED |
11th Mar 2021 | SOU EXTENSION 1 FILED |
11th Mar 2021 | TEAS EXTENSION RECEIVED |